Search

everythinglearnresearchcommunity

for

Search:↓

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

Certain compounds from Stephania cepharantha help hair cell growth.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Blocking certain brain processes reduces mating behavior in female rats.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Testosterone, 4-hydroxyandrostenedione, and finasteride affect blood clotting differently in stressed heart conditions.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

A new compound effectively inhibits human 5α-reductase 1.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

5α-reductases increase epitestosterone's effect on androgen receptors.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.